HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹678 Cr | ₹653 Cr | ₹662 Cr | ₹670 Cr | ₹562 Cr |
What is the latest Total Liabilities ratio of HESTER BIOSCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹678 Cr |
| Mar2025 | ₹653 Cr |
| Mar2024 | ₹662 Cr |
| Mar2023 | ₹670 Cr |
| Mar2022 | ₹562 Cr |
How is Total Liabilities of HESTER BIOSCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹678 Cr | 3.76 | |
| Mar2025 | ₹653 Cr | -1.35 | |
| Mar2024 | ₹662 Cr | -1.14 | |
| Mar2023 | ₹670 Cr | 19.18 | |
| Mar2022 | ₹562 Cr | - | |
Compare Total Liabilities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,838.7 Cr | 0.1% | 12.7% | 19.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 0.1% |
12.7% |
19.7% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses